XCUR News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

XC

Mkt Cap

$7.3M

Volume

32.52K

Next Earnings

November 6th

Chart Financials Earnings News About Insider Filings

Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-QExicure, Inc. (Nasdaq: XCUR) received a notification from Nasdaq on May 28, 2026 for non-compliance with listing rules due to delayed filing of its Q1 2026 Form 10-Q. The delay was attributed to changes in financial reporting personnel and procedures. The company filed the report on May 29, 2026 and believes it has regained compliance.GlobeNewswire Inc. · Jun 1, 2026

Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)Exicure, Inc. announced a co-development agreement with Korea-based Adbiotech to explore combination therapies using Burixafor (GPC-100) across multiple therapeutic areas including sickle cell disease, acute myeloid leukemia, and solid tumors. Adbiotech will conduct in vivo studies while Exicure provides Burixafor and leads clinical strategy. The collaboration aims to advance selected programs into IND-enabling studies and clinical trials with future funding to be secured.GlobeNewswire Inc. · Apr 22, 2026

Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing TransplantExicure announced publication of Phase 2 data for burixafor, a CXCR4 inhibitor, demonstrating rapid stem cell mobilization in multiple myeloma and lymphoma patients. The study showed 92% of participants met primary endpoints with same-day cell collection capability, significantly faster than currently approved alternatives. The drug was well-tolerated with minimal adverse events and showed potential applications beyond transplant including gene therapy and CAR-T approaches.GlobeNewswire Inc. · Feb 5, 2026

Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem MeetingsExicure, Inc. announced it will present positive Phase 2 trial data for burixafor at the 2026 Tandem Meetings in Salt Lake City. The trial evaluated burixafor's ability to mobilize hematopoietic progenitor cells in multiple myeloma patients undergoing autologous transplantation, with 89.7% of patients meeting the primary endpoint and demonstrating a favorable safety profile with same-day administration.GlobeNewswire Inc. · Jan 21, 2026

Exicure, Inc. Reports Third Quarter 2025 Financial ResultsExicure reported a net loss of $2.4 million in Q3 2025, with reduced cash reserves and insufficient funding to continue operations. The company is exploring strategic alternatives and seeking additional financing.GlobeNewswire Inc. · Nov 7, 2025

Exicure Posts Wider Loss in Fiscal Q2Biotechnology company Exicure reported no revenue in Q2 2025, a widened net loss of $2.6 million, and a critical need for additional financing after acquiring GPCR Therapeutics USA Inc. The company is pivoting to focus on stem cell mobilization therapies for blood disorders.The Motley Fool · Aug 8, 2025

Why FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionShares of FMC Corporation (NYSE: FMC) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter results. FMC posted adjusted earnings of $1.07 per share, missing market estimates of $1.08 per share. The company’s quarterly sales came in at $1.15 billion versus expectations of $1.25 billion. FMC shares dipped 9.8% to $54.51 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) jumped 144.4% to $0.5427 after dipping around 26% on Monday. Tenax Therapeutics, Inc. (NASDAQ: TENX) jumped 96% to $17.13 after the company announced the USPTO granted notice of allowance for the U.S. patent application "Levosimendan For Treating Pulmonary Hypertension With Heart Failure With Preserved Ejection Fraction." Agrify Corporation (NASDAQ: AGFY) shares climbed 70.1% to $1.0889. Agrify achieved milestone with PX-30 hydrocarbon extraction system installation in Michigan Facility. ADDvantage Technologies Group, Inc. (NASDAQ: AEY) gained 36% to $0.4769. Palantir Technologies Inc. (NYSE: PLTR) shares surged 27% to $21.23 after the company reported better-than-expected fourth-quarter sales results and issued guidance. Zenvia Inc. (NASDAQ: ZENV) rose 25% to $1.4621. Zenvia announced agreements to address funding gap and introduced EBITDA guidance for 2024, with a range between BRL 120 million and BRL140 million. Helius Medical Technologies, Inc. (NASDAQ: HSDT) climbed 24% to $8.80. Helius Medical Technologies announced alignment with the FDA on registrational program for treatment of stroke patients. Exicure, Inc. (NASDAQ: XCUR) gained 21.7% to $0.67 after the company announced it entered ...Benzinga · Feb 6, 2024

Why Palantir Technologies Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving PremarketShares of Palantir Technologies Inc. (NYSE: PLTR) rose sharply during today’s pre-market trading after the company reported better-than-expected fourth-quarter sales results and issued guidance. Palantir said fourth-quarter revenue increased 20% year-over-year to $608 million, which beat the consensus estimate of $602.41 million, according to Benzinga Pro. Palantir reported quarterly adjusted earnings of 8 cents per share, which was in line with analyst estimates. Palantir expects first-quarter revenue to be between $612 million and $616 million versus estimates of $617.21 million. First-quarter adjusted income from operations is expected to be between $196 million and $200 million. Palantir Technologies shares jumped 18.2% to $19.77 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) gained 54.2% to $0.3424 in pre-market trading after dipping around 26% on Monday. Chenghe Acquisition Co. (NASDAQ: CHEA) shares jumped 43.2% to $10.08 in pre-market trading. Chenghe Acquisition shares jumped 28% on Monday after shareholders on Friday voted to approve the merger agreement with Taiwan Color Optics, Inc. Exicure, Inc. (NASDAQ: XCUR) gained 36.2% to $0.75 ...Benzinga · Feb 6, 2024

Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving PremarketShares of Richardson Electronics, Ltd. (NASDAQ: RELL) fell sharply in today’s pre-market trading after the company posted weaker-than-expected results for its second quarter. Richardson Electronics posted a quarterly loss of 13 cents per share, compared to market estimates for earnings of 1 cent per share. The company’s quarterly sales came in at $44.13 million versus estimates of $52.00 million, according to data from Benzinga Pro. Richardson Electronics shares dipped 13.2% to $10.85 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Atreca, Inc. (NASDAQ: BCEL) shares rose 53.2% to $0.1641 in pre-market trading after falling around 7% on Wednesday. Atreca, last month, announced the sale of a collection of antibody-related assets and materials to Immunome consisting of a $5.5 million upfront payment and up to $7.0 million in clinical development milestones. Bitcoin Depot Inc. (NASDAQ: BTM) shares jumped 31.8% to $3.48 in pre-market trading amid strength in the price of Bitcoin. U.S. regulators gave the green light to Bitcoin ETFs. Transphorm, Inc. (NASDAQ: TGAN) surged 30.6% to $4.95 in pre-market trading. after ...Benzinga · Jan 11, 2024

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionShares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results. WD-40 reported quarterly earnings of $1.28 per share which exceeded the analyst consensus estimate of $1.05 per share. The company reported quarterly sales of $140.42 million, clocking in above the Street's estimate of $134.37 million. WD-40 shares jumped 17.3% to $277.56 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Nauticus Robotics, Inc. (NASDAQ: KITT) climbed 87.8% to $0.5501. Nauticus Robotics secured additional funding and appointed John W. Gibson, Jr as interim CEO. Clearmind Medicine Inc. (NASDAQ: CMND) shares jumped 47.7% to $3.0570. Clearmind Medicine completed a Type A Meeting with the FDA for clinical trial of its proprietary MEAI-based, CMND-100 compound, for the treatment of alcohol use disorder. Sana Biotechnology, Inc. (NASDAQ: SANA) gained 46.8% to $7.57. Sana Biotechnology recently announced FDA clearance of investigational new drug application for SC262. Ucommune International Ltd (NASDAQ: UK) jumped 37.8% to $4.98. Vicarious Surgical Inc. (NASDAQ: RBOT) rose 37% to $0.6851. Nvni Group Limited (NASDAQ: NVNI) climbed 35.2% to $2.6091. EchoStar Corporation (NASDAQ: SATS) gained 31% to $16.50. EchoStar completed merger with DISH Network Corporation. Amarin Corporation plc (NASDAQ: AMRN) climbed 28.8% to $1.25 after the company reported strong preliminary FY23 total revenues. Exicure, Inc. (NASDAQ: XCUR) shares rose 17% to $0.5501. Exicure was granted broad U.S. patent #11866700 for "Liposomal Nucleic Acid Constructs Presenting Antisense Oligonucleotides For Knockdown Of Interleukin ...Benzinga · Jan 10, 2024

XC

XCURExicure, Inc. Common Stock

XCUR

Pay with—

Available Balance0.00

Your PositionYou don't own any XCUR yet.

Related Tickers

Earnings